Inhibiting translation initiation for androgen receptor-deficient prostate cancer
October 10, 2019 11:50 PM UTC
INDICATION: Prostate cancer...
Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
INDICATION: Prostate cancer...